Skip to Main Content

Author Details

Manuel Ridao
Instituto Aragones de Ciencias de la Salud (IIS Aragon)
1997
65
17
PMIDPaper TitleJournal TitlePublished Year
37939742Transparency, openness, and reproducible research practices are frequently underused in health economic evaluations.J Clin Epidemiol2024
36190489Has Arthroscopic Meniscectomy Use Changed in Response to the Evidence? A Large-database Study From Spain.Clin Orthop Relat Res2023
36834085Comparing Hospital Efficiency: An Illustrative Study of Knee and Hip Replacement Surgeries in Spain.Int J Environ Res Public Health2023
36822440A cross-sectional analysis identified co-authorship networks and scientific collaboration on reporting guidelines for health research.J Clin Epidemiol2023
35157020Mortality in Persons With Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis.JAMA Pediatr2022
35487732Design and methodological characteristics of studies using observational routinely collected health data for investigating the link between cancer and neurodegenerative diseases: protocol for a meta-research study.BMJ Open2022
36456022Revisiting systematic geographical variations in tonsils surgery in children in the Spanish National Health System: spatiotemporal ecological study on hospital administrative data.BMJ Open2022
32570677Strategy for the Analysis and Visualization of Electronic Medical Record Data for Public Hospitals in the City of Buenos Aires.Stud Health Technol Inform2020
32060160Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis.BMJ Open2020
32063380Factors underlying the growth of hospital expenditure in Spain in a period of unexpected economic shocks: A dynamic analysis on administrative data.Health Policy2020
32656302Starting the path of Digital Transformation in Health Innovation in Digital Health: Conference proceeding.Cienc Innov Salud2020
30554791A comparative performance analysis of a renowned public private partnership for health care provision in Spain between 2003 and 2015.Health Policy2019
31200773Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of observational studies.Syst Rev2019
30744675Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.Syst Rev2019
30837245Reporting guidelines for health research: protocol for a cross-sectional analysis of the EQUATOR Network Library.BMJ Open2019
30739817Public-private partnerships in the Spanish National Health System: The reversion of the Alzira model.Health Policy2019
30878246[Endorsement of guidelines for reporting economic evaluation studies by Spanish biomedical journals].Gac Sanit2019
31173122Association of Anorexia Nervosa With Risk of Cancer: A Systematic Review and Meta-analysis.JAMA Netw Open2019
28318755[Rapid assessments of the efficacy and safety of new medicinal products].Gac Sanit2018
30071062Quality and technical efficiency do not evolve hand in hand in Spanish hospitals: Observational study with administrative data.PLoS One2018
30200956Evolution of public hospitals expenditure by healthcare area in the Spanish National Health System: the determinants to pay attention to.BMC Health Serv Res2018
30277216Spain: Health System Review.Health Syst Transit2018
27567331Improving transparency of methods and results in cost-effectiveness analyses for cancer prevention, treatment and control.Med Clin (Barc)2017
28376926Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies.Syst Rev2017
28237952Factors associated with hospitalisations in chronic conditions deemed avoidable: ecological study in the Spanish healthcare system.BMJ Open2017
28915839Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies.Syst Rev2017
28700715The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.PLoS One2017
28594059Cost-effectiveness analyses in neuropsychiatry and mental health.Actas Esp Psiquiatr2017
28693568Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies.Syst Rev2017
28062088[Potential sponsorship bias in cost-effectiveness analyses of healthcare interventions: A cross-sectional analysis].Aten Primaria2017
27423243[Reporting of conflict of interest in cost-effectiveness analyses of healthcare interventions].Aten Primaria2017
26822374The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review.Syst Rev2016
26627379[Trend in potentially avoidable hospitalisations for chronic conditions in Spain].Gac Sanit2016
27507560Trends and area variations in Potentially Preventable Admissions for COPD in Spain (2002-2013): a significant decline and convergence between areas.BMC Health Serv Res2016
27445192Quality of Methods and Results Reporting in Cost-effectiveness Analyses of Cardiovascular Interventions.Rev Esp Cardiol (Engl Ed)2016
27063024[Improving the transparency and credibility of cost-effectiveness analysis of healthcare interventions].Rev Esp Salud Publica2016
26954482Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.PLoS Med2016
25690124Comparing variation across European countries: building geographical areas to provide sounder estimates.Eur J Public Health2015
25875125The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.Syst Rev2015
24491512[Variability and opportunity costs among the surgical alternatives for breast cancer].Gac Sanit2014
22498350Burden of disease assessment with summary measures of population health for the Region of Valencia, Spain: a population-based study.Med Clin (Barc)2013
24100772[Dabigatran versus acenocumarol for the prevention of stroke in atrial fibrillation: budget impact analysis in one health department in Spain].Rev Esp Salud Publica2013
23861972When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.PLoS One2013
23615217Trends of uncontrolled blood pressure in Spain: an updated meta-regression analysis.J Hypertens2013
23453596Cost-effectiveness of pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: qualitative synthesis of scientific evidence.Rev Psiquiatr Salud Ment2013
23218975Carpal tunnel release surgery: small-area variation and impact of ambulatory surgery in the autonomous region of Valencia, Spain.Gac Sanit2013
22025240Control of arterial hypertension in Spain: a systematic review and meta-analysis of 76 epidemiological studies on 341â¿¿632 participants.J Hypertens2012
23057832Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studies.BMC Psychiatry2012
22666435Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis.PLoS One2012
22257790Timing of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish National Health System.BMC Health Serv Res2012
  • 1 - 50 of 65

Recommended Authors

University of Oxford
Career Start Year 2016
Number of shared co-authors 0
National Institute for Health and Care Excellence
Career Start Year 2013
Number of shared co-authors 0
Institute of Health Economics, University of Alberta
Career Start Year 2010
Number of shared co-authors 0
Stanford University
Career Start Year 2010
Number of shared co-authors 0
Department of Health Services, Brown University School of Public Health
Career Start Year 2010
Number of shared co-authors 0
School of Public Health, University of Alberta
Career Start Year 2009
Number of shared co-authors 0
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 1
Evidence Foundation
Career Start Year 2008
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 0
Axtria Inc.
Career Start Year 2005
Number of shared co-authors 0
College of Public Health, Taipei Medical University
Career Start Year 2004
Number of shared co-authors 1
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Oregon Health & Science University-Portland State University School of Public Health
Career Start Year 2002
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 0
Fielding School of Public Health, University of California los angeles
Career Start Year 2002
Number of shared co-authors 0
Portland VA Healthcare System
Career Start Year 1999
Number of shared co-authors 0
Health Economics Research Centre, University of Oxford
Career Start Year 1997
Number of shared co-authors 0
University of Washington
Career Start Year 1997
Number of shared co-authors 0
Queens University Belfast
Career Start Year 1996
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
School of Public Health, Universite de Montreal 1
Career Start Year 1995
Number of shared co-authors 0
Stanford University
Career Start Year 1994
Number of shared co-authors 2
University Health Network
Career Start Year 1994
Number of shared co-authors 1
The University of Chicago
Career Start Year 1993
Number of shared co-authors 0
Virginia Commonwealth University
Career Start Year 1993
Number of shared co-authors 1
University of Sheffield
Career Start Year 1993
Number of shared co-authors 0
University of Southern California
Career Start Year 1992
Number of shared co-authors 0
Data Sciences Institute, Takeda Pharmaceuticals International Inc.
Career Start Year 1990
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 1
university of california san diego
Career Start Year 1983
Number of shared co-authors 0

Collaborators

Co-authored papers 9
University of Ottawa
Co-authored papers 7
Josep Carreras Leukaemia Research Institute (IJC)
Co-authored papers 6
Hospital Clinic, Institute of Neuroscience, University of Barcelona
Co-authored papers 4
University of Florida
Co-authored papers 1
Instituto de Salud Publica. FMED-UBA. Buenos Aires
Co-authored papers 1
Harvard T.H. Chan School of Public Health, MIT
Co-authored papers 1
Instituto de Efectividad Clinica y Sanitaria (IECS)
Co-authored papers 1